tiprankstipranks
Physiomics PLC (GB:PYC)
LSE:PYC

Physiomics Stock Analysis & Ratings

GB:PYC Stock Chart & Stats

Day’s Range0p - 0p
52-Week Range2.80p - 7.28p
Previous Close2.85p
Volume769.43K
Average Volume (3M)1.64M
Market CapN/A
Enterprise ValueN/A
P/E Ratio-11.8
Beta1.40
Next EarningsOct 04, 2022
EPS ForecastN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
1Y Price TargetN/A
Smart ScoreN/A


Financials

Yearly

P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.

---

GB:PYC FAQ

What was Physiomics’s price range in the past 12 months?
Physiomics lowest stock price was 2.80p and its highest was 7.28p in the past 12 months.
    What is Physiomics’s market cap?
    Currently, no data Available
    What is Physiomics’s price target?
    Currently, no data Available
    What do analysts say about Physiomics?
    Not enough analysts have published a price target to provide an average price target.
    When is Physiomics’s upcoming earnings report date?
    Physiomics’s upcoming earnings report date is Oct 04, 2022 which is in 93 days.
      How were Physiomics’s earnings last quarter?
      Physiomics released its earnings results on Mar 07, 2022. The company reported -0.1p earnings per share for the quarter, missing the consensus estimate of N/A by -0.1p.
        Is Physiomics overvalued?
        According to Wall Street analysts Physiomics’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Physiomics pay dividends?
          Physiomics does not currently pay dividends.
          What is Physiomics’s EPS estimate?
          Physiomics’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Physiomics have?
          Physiomics has 97,424,780 shares outstanding.
            What happened to Physiomics’s price movement after its last earnings report?
            Physiomics reported an EPS of -0.1p in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -3.529%.
              Which hedge fund is a major shareholder of Physiomics?
              Currently, no hedge funds are holding shares in GB:PYC

              ---

              Physiomics Stock Analysis

              Smart Score
              N/A
              Not Ranked
              1
              2
              3
              4
              5
              6
              7
              8
              9
              10
              Price Target
              No data currently available

              Analyst Forecast

              N/A
              Currently Not Enough Data Available

              Blogger Sentiment

              N/A
              Currently Not Enough Data Available

              Insider Transactions

              N/A
              Currently Not Enough Data Available

              News Sentiment

              N/A
              Currently Not Enough Data Available

              Technicals

              SMA
              Negative
              20 days / 200 days
              Momentum
              -56.81%
              12-Months-Change

              Fundamentals

              Return on Equity
              -22.22%
              Trailing 12-Months
              Asset Growth
              -7.74%
              Trailing 12-Months
              This stock does not have enough of the key information we need to rate it accurately. Smart Score is calculated for stocks traded in Nasdaq, NYSE, TSE and LSE with a market cap above $30M and average 3 months trading volume above $30K.
              Learn more about TipRanks Smart Score

              Company Description

              Physiomics PLC

              Physiomics PLC a United Kingdom-based firm providing services to pharmaceutical companies through outsourced systems and computational biology. The company is mainly engaged in the development of models to streamline the drug discovery and development process. It focuses on the development of Virtual Tumour Clinical used to predict optimal treatment for human clinical trials; Cardiac tox prediction service used to predict unwanted toxic side effects of drug candidates, and drug combinations database, for researchers and clinicians to access literature data on pre-clinical and clinical treatments and their effects.

              ---
              Similar Stocks
              Company
              Price & Change
              Follow
              Sareum Holdings
              ValiRx plc
              Nostra Terra Oil and Gas
              Scirocco Energy PLC
              Provexis

              Popular Stocks

              ---
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis